228 results on '"Megna D"'
Search Results
2. Rethinking Heart Retransplantation - Institutional Success Over Last Decade
3. Settling the Issue: Does Neupogen Increase the Risk of Rejection After Heart Transplant?
4. Impact of Institutional Volume on Outcomes Following DCD Heart Transplantation in the United States
5. Does Insulin-Dependent Diabetes in a Donor Impact Outcome After Heart Transplantation?
6. Randomized Trial to Evaluate the Safety and Efficacy of the Sherpa Pak Device versus Cold Storage of Donor Hearts in Transplantation: A Pilot Study
7. Robotic Lung Transplantation
8. (575) The Outcome of Heart Transplant Patients with Severe Rejection Requiring ECMO Support: Is it Futile
9. Thoracoabdominal Normothermic Regional Perfusion Does Not Adversely Impact Early Outcomes in Donation after Circulatory Death Lung Transplantation
10. Outcomes of Extremely Prolonged (> 50 Days) Venovenous Extracorporeal Membrane Oxygenation Support: A Single Center Experience
11. (193) Heart Retransplant Recipients with Borderline Renal Dysfunction Benefit from Combined Heart-Kidney Transplantation
12. (143) Impact of the 2018 Adult Heart Allocation Policy Change on the Incidence of Primary Graft Dysfunction after Heart Transplantation
13. (792) Does Right Ventricular Support with Mechanical Assist Devices Compromise Outcome for Heart Transplantation?
14. Sloshing Behavior in Rigid and Flexible Propellant Tanks: Computations and Experimental Validation
15. Comparisons of TEG Versus Standard Heparin Monitoring Assays in Covid Positive VV ECMO
16. Esophageal pH and Timing of CLAD in Lung Transplant Recipients
17. Should Age-Based Eligibility Thresholds Differ for Repeat Heart Transplantation? Analysis of the United Network of Organ Sharing Database
18. Donor Derived Coccidioides in a Lung Transplant Recipient
19. Intra-Aortic Balloon Pump or Impella 5.0/5.5 as a Bridge to Heart Transplantation?
20. Complexities of Explanting Durable LVADs (Done at Outside Facilities) at the Time of Heart Transplant Surgery
21. Extracorporeal Membrane Oxygenation as a Bridge to Total Artificial Hearts
22. Is There Heterogeneity on Outcome of Hospitalized Heart Transplant Patients with COVID-19 Infection Across the US?
23. Orthotopic Lung Transplantation in Patients over Seventy Years of Age
24. Survival Benefit of Lung Transplant in Septuagenarians: A United Network of Organ Sharing Database Analysis
25. Does Overnight Heart Transplantation Lead to Worse Outcomes? Results from a High Volume Transplant Center
26. Feeling the Burn: Esophageal PH and CLAD
27. Acute Abdomen Complications Immediately Following Heart Transplantation: What Are the Odds?
28. ACEi Use in Select Patients Awaiting Heart Transplant May Be a Risk Factor for the Development of Primary Graft Dysfunction and Vasoplegia
29. Outcomes of Heart Re-Transplantation with Combined Kidney Transplant
30. Impact of Minimally Invasive Lung Transplantation on Early Outcomes and Analgesia Use: A Matched Cohort Study
31. Actual Size Mismatch in Lung Transplantation for Restrictive Lung Disease
32. Experience with Eculizumab in Highly Sensitized Patients Undergoing Heart Transplantation
33. (299) - Randomized Trial to Evaluate the Safety and Efficacy of the Sherpa Pak Device versus Cold Storage of Donor Hearts in Transplantation: A Pilot Study
34. (1285) - Verticalization Therapy: Safety and Efficacy in the Cardiac Surgery ICU
35. (1108) - Settling the Issue: Does Neupogen Increase the Risk of Rejection After Heart Transplant?
36. (748) - Does Insulin-Dependent Diabetes in a Donor Impact Outcome After Heart Transplantation?
37. (323) - Novel Machine Learning Models for Predicting 3 Year Survival in Adult Heart Transplant
38. (281) - Rethinking Heart Retransplantation - Institutional Success Over Last Decade
39. (7) - Impact of Institutional Volume on Outcomes Following DCD Heart Transplantation in the United States
40. Warm Ischemic Time in Orthotopic Heart Transplantation: Is Faster Really Better?
41. Donor Heart Coronary Calcification: Do We Take This Donor Heart?
42. Do Heart-Kidney Transplant Candidates on Mechanical Circulatory Support Have Acceptable Outcomes Post-Transplant?
43. Incidence of Heparin Induced Thrombocytopenia in Patients Undergoing Implantation of Durable and Non-Durable Mechanical Circulatory Support Devices
44. Landscape of Heart Transplantation Following Changes in UNOS Donor Allocation Policy
45. Heparin-Induced Thrombocytopenia and Thrombosis with Axillary Impella 5.5 as Bridge-to-Transplant
46. Heart in the Box with Long Term Outcome Post-Heart Transplantation
47. The Effects of the New Donor Heart Allocation Policy on Temporary Device Utilization and Outcomes: A Single Center Experience
48. Long-Term Effects of Monotherapy with Low Dose Tacrolimus
49. Apparent Immune Effect of Clostridium Difficile in Post-Heart Transplant Recipients
50. Outcomes of Temporary Percutaneous Right Ventricular Assist Devices in Right Ventricular Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.